Rodabe N Amaria

20PUBLICATIONS
158CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Apr 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

|Feb 20, 2026
Erythrocyte-antibody conjugates to overcome immunotherapy resistance.

Urvashi Mitbander Joshi, Rodabe N Amaria

|Sep 24, 2025
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Georgina V Long, Nitya Nair, Daniel Marbach

|Jul 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu

|May 14, 2024
Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of Immunotherapy.

Mathangi Gopalakrishnan, Rodabe N Amaria

Pageof 4

Frequent Collaborators

12 joint publications

Michael A Davies

10 joint publications

Hussein A Tawbi

8 joint publications

Sapna Patel

8 joint publications

Jennifer A Wargo